skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Mild versus severe COVID-19: Laboratory markers

International journal of infectious diseases, 2020-06, Vol.95, p.304-307 [Peer Reviewed Journal]

2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2020 The Author(s) 2020 ;ISSN: 1201-9712 ;EISSN: 1878-3511 ;DOI: 10.1016/j.ijid.2020.04.061 ;PMID: 32344011

Full text available

Citations Cited by
  • Title:
    Mild versus severe COVID-19: Laboratory markers
  • Author: Velavan, Thirumalaisamy P. ; Meyer, Christian G.
  • Subjects: Betacoronavirus ; Biomarkers ; Biomarkers - blood ; Coronavirus Infections - blood ; Coronavirus Infections - diagnosis ; COVID-19 ; Humans ; Intensive Care Units ; Laboratory markers ; Mild and severe COVID-19 ; Pandemics ; Pneumonia, Viral - blood ; Pneumonia, Viral - diagnosis ; SARS-CoV-2
  • Is Part Of: International journal of infectious diseases, 2020-06, Vol.95, p.304-307
  • Description: •Several laboratory parameters may facilitate the assessment of COVID-19 severity•Discriminating mild from severe COVID-19 disease•Cumulative data from clinical characteristics of COVID-19 patients•Low lymphocyte count as well as the serum levels of CRP, D-dimers, ferritin and IL-6 The number of COVID-19 patients is dramatically increasing worldwide. Treatment in intensive care units (ICU) has become a major challenge; therefore, early recognition of severe forms is absolutely essential for timely triaging of patients. While the clinical status, in particular peripheral oxygen saturation (SpO2) levels, and concurrent comorbidities of COVID-19 patients largely determine the need for their admittance to ICUs, several laboratory parameters may facilitate the assessment of disease severity. Clinicians should consider low lymphocyte count as well as the serum levels of CRP, D-dimers, ferritin, cardiac troponin and IL-6, which may be used in risk stratification to predict severe and fatal COVID-19 in hospitalised patients. It is more likely that the course of the disease will be unfavourable if some or all of these parameters are altered.
  • Publisher: Canada: Elsevier Ltd
  • Language: English
  • Identifier: ISSN: 1201-9712
    EISSN: 1878-3511
    DOI: 10.1016/j.ijid.2020.04.061
    PMID: 32344011
  • Source: Freely Accessible Journals
    MEDLINE
    Directory of Open Access Journals

Searching Remote Databases, Please Wait